Weidenbacher, Payton A.-B. http://orcid.org/0000-0002-7692-0458
Sanyal, Mrinmoy http://orcid.org/0000-0002-1365-4279
Friedland, Natalia
Tang, Shaogeng
Arunachalam, Prabhu S. http://orcid.org/0000-0003-0090-5689
Hu, Mengyun http://orcid.org/0000-0003-4495-7501
Kumru, Ozan S. http://orcid.org/0000-0002-5010-7223
Morris, Mary Kate
Fontenot, Jane
Shirreff, Lisa http://orcid.org/0000-0002-8403-451X
Do, Jonathan
Cheng, Ya-Chen
Vasudevan, Gayathri
Feinberg, Mark B.
Villinger, Francois J.
Hanson, Carl
Joshi, Sangeeta B.
Volkin, David B.
Pulendran, Bali http://orcid.org/0000-0001-6517-4333
Kim, Peter S. http://orcid.org/0000-0001-6503-4541
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K99HD104924)
Damon Runyon Cancer Research Foundation
Article History
Received: 19 December 2022
Accepted: 16 March 2023
First Online: 17 April 2023
Change Date: 5 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-42061-4
Competing interests
: P.A.B.W., M.S., N.F., S.T., and P.S.K. are named as inventors on patent applications applied for by Stanford University and the Chan Zuckerberg Biohub on immunogenic coronavirus fusion proteins and related methods, which have been licensed to Vaccine Company, Inc. P.A.B.W. is an employee of, and P.S.K. is a co-founder and member of the Board of Directors of Vaccine Company, Inc. All other authors declare no competing interests.